Brexit Could Quell UK’s Voice In EU Medtech Regs Debate
This article was originally published in Clinica
The UK has always been a highly active authority in leading discussions and initiating action in the EU medtech regulatory space. Arguably, along with France, it has been the most active among its other EU counterparts. So what will the UK’s influence be if it votes to leave the EU during the June 23 referendum and would the EU’s medtech rules still apply? Clinica’s Amanda Maxwell sought the opinions of Alexander Denoon and Erik Vollebregt.
You may also be interested in...
It seems to be game over for anyone who might have been hoping the European Commission would do a U-turn on its decision to use the Italian CND nomenclature as the basis for communication in Eudamed, instead of the well-established GMDN. But GMDN is strong in its resolve to remain a vital global nomenclature service.
2020 is not getting off to a good start for manufacturers needing to comply with the EU’s new Medical Device Regulation on 26 May 2020. The European Commission’s latest document seems to confirm industry’s fears about the ability of the EU’s medtech system to be ready in time.
December 2019 was a big month for far-reaching EU medtech regulatory developments that will have a significant impact on the way and speed of implementation of the Medical Device Regulation.